Evidence map›Paper›PMID 34881308›Full record

ArticleFrontiers in cardiovascular medicine2021

Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men.

Hiroshi Yoshida, Kumie Ito, Daisuke Manita, Ryo Sato, Chika Hiraishi, Sadako Matsui, Yuji Hirowatari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Hiroshi YoshidaDepartment of Laboratory Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan.
Kumie ItoNihonbashi Sakura Clinic, Tokyo, Japan.
Daisuke ManitaBioscience Division, TOSOH Corporation, Kanagawa, Japan.
Ryo SatoDepartment of Laboratory Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan.
Chika HiraishiInternal Medicine of Metabolism and Nutrition, The Jikei University Graduate School of Medicine, Tokyo, Japan.
Sadako MatsuiDepartment of Food and Nutrition, Faculty of Human Sciences and Design, Japan Women's University, Tokyo, Japan.
Yuji HirowatariDepartment of Health Science, Laboratory Science, Saitama Prefectural University, Saitama, Japan.
Jikei University School of Medicine · JPJapan Women's University · JPJikei University Kashiwa hospital · JPOsaka Nishi Clinic · JPSaitama Prefectural University · JPTosoh (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Framingham risk scoreIDL-cholesterolNon-HDL cholesterolSuita scoreVLDL-cholesterol

Identifiers

PMID34881308
PMCPMC8645599
OpenAlexW4200447406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.